0.51 USD
↘ 0.01 (2.21%)LIVE (AS OF 03:23 PM EDT)
Humacyte, Inc. Common Stock
HUMANASDAQ • USD
Market: OPEN
Shares of Humacyte, Inc. Common Stock (HUMA) are trading at $0.51. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, HUMA trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 2, 2026.
Open?$0.52
High?$0.54
Low?$0.49
Prev. Close?$0.52
Volume?5.7M
Avg. Volume?4.8M
VWAP?$0.50
Rel. Volume?1.19x
Bid / Ask
Bid?$0.48 × 900
Ask?$0.57 × 200
Spread?$0.09
Midpoint?$0.52
Valuation & Ratios
Market Cap?144.5M
Shares Out?277.8M
Float?245.5M
Float %?88.4%
P/E Ratio?N/A
P/B Ratio?4.62
EPS?-$0.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Employees
184
Market Cap
144.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-08-27
Address
2525 EAST NORTH CAROLINA HIGHWAY 54
DURHAM, NC 27713
Phone: 919-313-9633
DURHAM, NC 27713
Phone: 919-313-9633
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?57
Short Sent.?29
Piotroski F-Score?4/9Mixed
Altman Z-Score?-9.14Distress
Confidence?55%Low
Short InterestHigh
Short % of Float?12.96%High
Short Interest?31.8M
Days to Cover?7.3
Free Float245.5M
Avg Daily Volume4.4M
Settlement Date2026-09-15
Financial Health
Current Ratio?6.21Strong
Quick Ratio?5.74Strong
Cash Ratio?5.35Strong
Debt/Equity?2.12High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?4.62FAIR▾
Peers100
S&P39
P/S?68.11HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
S&P97
EV/Sales?61.64HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-309.4%WEAK▾
S&P3
ROA?-70.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-97560000
Enterprise Value?$130.7M
Fundamentals ratios updated end of day